FdaApplication
NDA 214801
Identifiers
- fda_app_no: NDA214801
Properties
| Property | Value |
|---|---|
| applicant_name | TAIHO ONCOLOGY INC |
| application_type | NDA |
| approval_date | 2022-09-30 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LYTGOBI | FUTIBATINIB | 4MG | TABLET;ORAL |
| LYTGOBI | FUTIBATINIB | 16MG | TABLET;ORAL |
2 products